HACE2.16 for COVID-19

 HACE2.16 has been reported as potentially beneficial for COVID-19 in the following study.
COVID-19 involves the interplay of 350+ viral and host proteins and factors providing many therapeutic targets. Scientists have proposed 10,000+ potential treatments. c19early.org analyzes 210+ treatments. We have not reviewed hACE2.16 in detail.
Chaouat et al., Anti-human ACE2 antibody neutralizes and inhibits virus production of SARS-CoV-2 variants of concern, iScience, doi:10.1016/j.isci.2022.104935